Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Dobmeier currently holds 8,350 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Dobmeier has been a net seller of ADPT stock. They have purchased $602.1K and sold $38.8M worth of shares.
Eric Dobmeier's most recent insider trade was on Jul 19, 2024, when they sold 8,350 shares at $0.00 per share.
Eric Dobmeier serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 386 insider transactions totaling $39.4M over their tenure at the company.
Eric Dobmeier holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Eric Dobmeier has shown a selling trading pattern, with $602.1K in total purchases and $38.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Dobmeier was on Dec 1, 2022, when they sold $669.3K worth of KDNY shares. This transaction involved 30,000 shares at $22.31 per share.
Eric Dobmeier currently owns 8,350 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Dobmeier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Dobmeier has 386 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Eric Dobmeier and 40,000+ other insiders.